tirzepatide maintenance dose after weight loss Zepbound Goal Weight: Next Steps Using Tirzepatide for wieght loss

We Can Be Your Guiding Light Schedule your complimentary consultation to explore our services and find a path forward for your treatment

Clinical evidence The SURMOUNT-1 trial found that participants without diabetes lost an average of 22.5% of body weight at the 15 mg dose after 72 weeks

Recommending a treatment requires confidence, and that confidence comes from data

Castro recommends focusing on strength training in your day-to-day activity, while Gervacio recommends creating a plan focused on your own fitness levels and goals

AU TGA pregnancy category: D US FDA pregnancy category: Not assigned Risk summary: Insufficient data available on use of this drug in pregnant women to inform a drug-related risk

If appetite suppression stalls before reaching your weight loss goals, your PlexusDx provider can escalate your dose at the same flat monthly rate, ensuring financial predictability throughout your treatment